0
To authorize the President to enter into trade agreements for the reciprocal elimination of duties or other import restrictions with respect to medical goods to contribute to the national security and public health of the United States, and for other purposes.
3/19/2025, 8:05 AM
Summary of Bill HR 2213
The bill emphasizes the importance of ensuring a stable and reliable supply of medical goods, especially in times of crisis such as pandemics or natural disasters. By reducing barriers to trade, the United States can better access essential medical supplies and equipment from other countries.
In addition to promoting the reciprocal elimination of duties on medical goods, the bill also includes provisions for monitoring and enforcing these trade agreements. This ensures that the United States is able to benefit from increased access to medical goods while also protecting domestic industries. Overall, the Medical Goods Trade Agreement Act seeks to strengthen the United States' ability to respond to public health emergencies and ensure the availability of critical medical supplies. It is a bipartisan effort to improve national security and public health through international trade agreements.
Congressional Summary of HR 2213
Medical Supply Chain Resiliency Act
This bill authorizes actions to facilitate trade in medical goods (i.e., medical devices, pharmaceutical goods, or inputs for such devices or goods).
Specifically, the bill authorizes the President to (1) negotiate, enter into, and enforce a trusted trade partner agreement with a country or countries with respect to medical goods; and (2) proclaim a modification of any existing duty, a continuance of existing duty-free or excise treatment, or additional duties to carry out the trade agreement. These actions may only be taken if the President determines, based on specified considerations, that the reciprocal elimination of existing duties or other import restrictions with respect to medical goods would contribute to U.S. national security and public health.
A trusted trade partner agreement may include certain provisions, such as those to (1) reduce or eliminate duties, quotas, or other trade barriers; (2) diversify and expand supplier networks to secure a reliable supply of medical goods; and (3) harmonize regulatory procedures.
Not later than 60 days before initiating negotiations with a trusted trade partner, the President must submit written notice to Congress. The bill requires congressional consultation and review of these trade agreements. A trade agreement shall not take effect if, during the required review period, Congress enacts a joint resolution of disapproval.
The Office of the U.S. Trade Representative must monitor compliance by a trusted trade partner with the trade agreement's commitments and obligations. Further, the President may take certain actions in response to a failure to comply.
